- Record: found
- Abstract: found
- Article: not found
The TRAIL apoptotic pathway in cancer onset, progression and therapy.
2008-09-30
Animals, Antineoplastic Combined Chemotherapy Protocols, pharmacology, therapeutic use, Apoptosis, Disease Models, Animal, Genetic Predisposition to Disease, Humans, Mice, Neoplasms, drug therapy, genetics, metabolism, Receptors, Death Domain, antagonists & inhibitors, Receptors, TNF-Related Apoptosis-Inducing Ligand, Recombinant Proteins, Signal Transduction, TNF-Related Apoptosis-Inducing Ligand, agonists
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Related collections
Author and article information
Animals,Antineoplastic Combined Chemotherapy Protocols,pharmacology,therapeutic use,Apoptosis,Disease Models, Animal,Genetic Predisposition to Disease,Humans,Mice,Neoplasms,drug therapy,genetics,metabolism,Receptors, Death Domain,antagonists & inhibitors,Receptors, TNF-Related Apoptosis-Inducing Ligand,Recombinant Proteins,Signal Transduction,TNF-Related Apoptosis-Inducing Ligand,agonists
Animals, Antineoplastic Combined Chemotherapy Protocols, pharmacology, therapeutic use, Apoptosis, Disease Models, Animal, Genetic Predisposition to Disease, Humans, Mice, Neoplasms, drug therapy, genetics, metabolism, Receptors, Death Domain, antagonists & inhibitors, Receptors, TNF-Related Apoptosis-Inducing Ligand, Recombinant Proteins, Signal Transduction, TNF-Related Apoptosis-Inducing Ligand, agonists